n-methylaspartate has been researched along with olanzapine in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duhan, NL; Farber, NB; Foster, J; Olney, JW | 1 |
Moore, N | 1 |
Breier, A | 1 |
Arvanov, V; Jardemark, KE; Liang, X; Wang, RY | 1 |
Jardemark, KE; Ninan, I; Wang, RY | 1 |
Dall'Olio, R; Gaggi, R; Gandolfi, O; Voltattorni, M | 1 |
Björkholm, C; Jardemark, K; Malmerfelt, A; Marcus, MM; Svensson, TH | 1 |
Aktan, G; Avcıoglu, S; Gokce, FM; Kaya, M; Onder, HI; Tunc, M; Yıldırım, U; Yuksel, H | 1 |
Carvalheira, R; Labbate, G; Longo, BM; Medeiros, P; Melo-Thomas, L; Silva, RC; Zangrando, J | 1 |
Bogus, K; Filipczyk, Ł; Krzystanek, M; Pałasz, A; Rojczyk, E; Wiaderkiewicz, A; Wiaderkiewicz, R; Worthington, J | 1 |
Belardo, C; Bertolino, A; Bolognesi, P; Errico, F; Frassineti, M; Iannotta, M; Maione, S; Morari, M; Motta, Z; Novellis, V; Nuzzo, T; Paolone, G; Pollegioni, L; Rosini, E; Sacchi, S; Squillace, M; Usiello, A | 1 |
2 review(s) available for n-methylaspartate and olanzapine
Article | Year |
---|---|
[Olanzapine: preclinical pharmacology and recent findings].
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; N-Methylaspartate; Olanzapine; Pirenzepine; Pyramidal Tracts; Receptors, Adrenergic; Receptors, Dopamine; Receptors, Muscarinic; Receptors, Serotonin | 1998 |
Cognitive deficit in schizophrenia and its neurochemical basis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Glutamic Acid; Haloperidol; Humans; N-Methylaspartate; Olanzapine; Pirenzepine; Risperidone; Schizophrenia; Schizophrenic Psychology | 1999 |
9 other study(ies) available for n-methylaspartate and olanzapine
Article | Year |
---|---|
Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzazepines; Dibenzoxazepines; Dizocilpine Maleate; Female; N-Methylaspartate; Nervous System; Olanzapine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1996 |
Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Synergism; Electrophysiology; Excitatory Amino Acid Agonists; Haloperidol; In Vitro Techniques; Male; N-Methylaspartate; Olanzapine; Pharmaceutical Vehicles; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Time Factors | 2000 |
Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Haloperidol; Male; Membrane Potentials; N-Methylaspartate; Olanzapine; Patch-Clamp Techniques; Phencyclidine; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2003 |
Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; N-Methylaspartate; Olanzapine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Agonists | 2003 |
Reboxetine enhances the olanzapine-induced antipsychotic-like effect, cortical dopamine outflow and NMDA receptor-mediated transmission.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Benzodiazepines; Cerebral Cortex; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Freezing Reaction, Cataleptic; In Vitro Techniques; Male; Membrane Potentials; Microdialysis; Morpholines; N-Methylaspartate; Olanzapine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reboxetine; Receptors, N-Methyl-D-Aspartate | 2010 |
Neuroprotective effects of olanzapine in N-methyl-D-aspartate-induced retinal injury.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Ischemia; Male; Malondialdehyde; N-Methylaspartate; Neuroprotective Agents; Olanzapine; Rats; Rats, Wistar; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Neurons | 2013 |
Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Inferior Colliculi; Male; Microinjections; N-Methylaspartate; Olanzapine; Psychoacoustics; Rats; Rats, Wistar; Reflex, Startle; Sensory Gating | 2013 |
Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Diencephalon; Down-Regulation; Haloperidol; Hippocampus; Hypothalamus; Male; N-Methylaspartate; Neocortex; Olanzapine; Protein Subunits; Rats; Rats, Sprague-Dawley; Up-Regulation | 2016 |
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity.
Topics: Animals; Benzodiazepines; Clozapine; D-Aspartate Oxidase; Dose-Response Relationship, Drug; Enzyme Activation; Glutamic Acid; Humans; Male; Mice; Mice, Knockout; N-Methylaspartate; Olanzapine; Prefrontal Cortex; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors | 2017 |